It was reported that linc01133 plays oncogenic roles in pancreatic cancer, hepatocellular carcinoma, renal cell carcinoma, endometrial carcinoma and cervical squamous carcinoma, while in colorectal carcinoma, linc01133 inhibits the malignant progression [5, 6]. This evidence concerns the gene LINC01133 and hepatocellular carcinoma.